Tocilizumab Injection (Subcutaneous Injection)

Roche Registration GmbH🇨🇳 National Medical Products Administration

Approval Id: 8FWSEbYSJj0
Approval Number: 国药准字SJ20220013
Generic Name: 托珠单抗注射液(皮下注射)
Generic Name En: Tocilizumab Injection (Subcutaneous Injection)
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 162mg/0.9ml/支
Reg Date: 2022-04-08
Expired Date: 2027-04-07
Company Name: Roche Registration GmbH
Production Company Name: Vetter Pharma-Fertigung GmbH & Co. KG
Company Detail Path: /organization/roche-registration-gmbh
Production Company Detail Path: /organization/vetter-pharma-fertigung-gmbh-and-co-kg

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Apr 8, 2022

Approval ID

8FWSEbYSJj0

Type

生物制品